Dr Reddy's Q4 Net Profit Jumps 3-Fold To Rs 337.6 Crore
New Delhi: Dr Reddy's Laboratories today reported a near three-fold jump in consolidated net profit to Rs 337.6 crore for the fourth quarter ended March 31, 2017.
The company had posted a net profit after taxes and shares of associates of Rs 122.6 crore for the corresponding period of the previous fiscal, Dr Reddy's Laboratories said in a BSE filing.
However, consolidated total income of the company declined to Rs 3,632.4 crore for the quarter under consideration as against Rs 3,880 crore for the same period year ago.
The net profit for the fiscal year ended March 2017 stood at Rs 1,292.1 crore as against Rs 2,130.6 crore for the previous fiscal.
Consolidated total income of the company stood at Rs 14,367.6 crore for the fiscal year ended March this year. It was Rs 15,863.3 crore for the same period year ago.
In a separate filing, the company said its board has recommended a final dividend of Rs 20 per equity share of Rs 5 face value for the financial year 2016-17.
Shares of the company were trading 0.14 per cent down at Rs 2,588.75 on BSE.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
